Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100,240, on endocrine and renal functions in healthy volunteers - Rousso, P; Buclin, T; Nussberger, J; Décosterd, L A; La Roche, S D; Brunner-Ferber, F; Brunner, H R; Biollaz, J (Journal of hypertension, 1999)
Keywords: Adult; Angiotensin II - blood; Angiotensin-Converting Enzyme Inhibitors - pharmacology; Atrial Natriuretic Factor - blood; Atrial Natriuretic Factor - urine; Benzazepines - pharmacology; Blood Pressure - drug effects; Cross-Over Studies; Cyclic GMP - urine; Diet, Sodium-Restricted; Endocrine System - drug effects; Follow-Up Studies; Humans; Infusions, Intravenous; Kidney - drug effects; Male; Neprilysin - antagonists & inhibitors; Neprilysin - blood; Peptidyl-Dipeptidase A - blood; Peptidyl-Dipeptidase A - drug effects; Posture; Pyridines - pharmacology; Reference Values; Renal Plasma Flow, Effective - drug effects; Safety; Stereoisomerism